108 related articles for article (PubMed ID: 33561825)
1. Impact of Facility Surgical Volume on Survival in Patients With Cancer.
Stoltzfus KC; Shen B; Tchelebi L; Trifiletti DM; Gusani NJ; Walter V; Wang M; Zaorsky NG
J Natl Compr Canc Netw; 2021 May; 19(5):495-503. PubMed ID: 33561825
[TBL] [Abstract][Full Text] [Related]
2. Is Treatment at a High-volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors?
Malik AT; Alexander JH; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Mar; 478(3):631-642. PubMed ID: 31714413
[TBL] [Abstract][Full Text] [Related]
3. Impact of radiation therapy facility volume on survival in patients with cancer.
Tchelebi LT; Shen B; Wang M; Gusani NJ; Walter V; Abrams R; Verma V; Zaorsky NG
Cancer; 2021 Nov; 127(21):4081-4090. PubMed ID: 34398470
[TBL] [Abstract][Full Text] [Related]
4. Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers?
Lazarides AL; Kerr DL; Nussbaum DP; Kreulen RT; Somarelli JA; Blazer DG; Brigman BE; Eward WC
Clin Orthop Relat Res; 2019 Apr; 477(4):718-727. PubMed ID: 30485258
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer.
Bajaj A; Martin B; Bhasin R; Hentz C; Block AM; Harkenrider MM; Solanki AA
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):851-857. PubMed ID: 29485062
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Radiation Facility Volume and Survival in Men With Lymph Node-Positive Prostate Cancer Treated With Radiation and Androgen Deprivation Therapy.
Patel SA; Goyal S; Liu Y; Moghanaki D; Patel PR; Hanasoge S; Dhere VR; Shelton JW; Godette KD; Jani AB; Hershatter B; Fischer-Valuck BW
JAMA Netw Open; 2020 Dec; 3(12):e2025143. PubMed ID: 33301015
[TBL] [Abstract][Full Text] [Related]
7. The impact of treatment facility type on the survival of brain metastases patients regardless of the primary cancer type.
Amin S; Baine M; Meza J; Lin C
BMC Cancer; 2021 Apr; 21(1):387. PubMed ID: 33836694
[TBL] [Abstract][Full Text] [Related]
8. Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer.
Chen YW; Mahal BA; Muralidhar V; Nezolosky M; Beard CJ; Den RB; Feng FY; Hoffman KE; Martin NE; Orio PF; Nguyen PL
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):683-90. PubMed ID: 26972640
[TBL] [Abstract][Full Text] [Related]
9. Facility Volume as a Prognosticator of Survival in Locally Advanced Papillary Thyroid Cancer.
Abiri A; Pang JC; Roman K; Goshtasbi K; Birkenbeuel JL; Kuan EC; Tjoa T; Haidar YM
Laryngoscope; 2023 Feb; 133(2):443-450. PubMed ID: 35822421
[TBL] [Abstract][Full Text] [Related]
10. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Hospital Volume on Breast Cancer Mortality.
Greenup RA; Obeng-Gyasi S; Thomas S; Houck K; Lane WO; Blitzblau RC; Hyslop T; Hwang ES
Ann Surg; 2018 Feb; 267(2):375-381. PubMed ID: 27893532
[TBL] [Abstract][Full Text] [Related]
12. Facility volume-survival relationship in patients with early-stage pancreatic adenocarcinoma treated with neoadjuvant chemotherapy followed by pancreatoduodenectomy.
Hue JJ; Sugumar K; Markt SC; Hardacre JM; Ammori JB; Rothermel LD; Winter JM; Ocuin LM
Surgery; 2021 Jul; 170(1):207-214. PubMed ID: 33454134
[TBL] [Abstract][Full Text] [Related]
13. Impact of treating facilities' type and volume in patients with major salivary gland cancer.
Bollig CA; Zitsch RP
Laryngoscope; 2019 Oct; 129(10):2321-2327. PubMed ID: 30698823
[TBL] [Abstract][Full Text] [Related]
14. Association between facility volume and mortality of patients with classic Hodgkin lymphoma.
Goyal G; Tella SH; Funni S; Kommalapati A; Inselman JW; Shah ND; Go RS; Ansell SM
Cancer; 2020 Feb; 126(4):757-764. PubMed ID: 31714588
[TBL] [Abstract][Full Text] [Related]
15. Influence of the facility caseload on the subsequent survival of men with localized prostate cancer undergoing radical prostatectomy.
Barzi A; Lara PN; Tsao-Wei D; Yang D; Gill IS; Daneshmand S; Klein EA; Pinski JK; Penson DF; Quinn DI; Sadeghi S
Cancer; 2019 Nov; 125(21):3853-3863. PubMed ID: 31398279
[TBL] [Abstract][Full Text] [Related]
16. Impact of Facility Type and Surgical Volume on 10-Year Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.
Chapman BC; Paniccia A; Hosokawa PW; Henderson WG; Overbey DM; Messersmith W; McCarter MD; Gleisner A; Edil BH; Schulick RD; Gajdos C
J Am Coll Surg; 2017 Mar; 224(3):362-372. PubMed ID: 27923615
[TBL] [Abstract][Full Text] [Related]
17. Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma.
Lee GC; Gamblin TC; Fong ZV; Ferrone CR; Goyal L; Lillemoe KD; Blaszkowsky LS; Tanabe KK; Qadan M
Ann Surg Oncol; 2019 Nov; 26(12):4091-4099. PubMed ID: 31368018
[TBL] [Abstract][Full Text] [Related]
18. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
[TBL] [Abstract][Full Text] [Related]
19. The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era.
Chen YW; Ornstein MC; Wood LS; Allman KD; Martin A; Beach J; Gilligan T; Garcia JA; Rini BI
Urol Oncol; 2018 Oct; 36(10):470.e19-470.e29. PubMed ID: 30131292
[TBL] [Abstract][Full Text] [Related]
20. Facility patient volume and survival among individuals diagnosed with malignant central nervous system tumors.
Johnson KJ; Barnes JM; Delavar A; O'Connell CP; Wang X
J Neurooncol; 2023 Jan; 161(1):117-126. PubMed ID: 36609808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
